166 related articles for article (PubMed ID: 36764011)
1. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.
Doghish AS; Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Fathi D; Elsakka EGE
Pathol Res Pract; 2023 Mar; 243():154363. PubMed ID: 36764011
[TBL] [Abstract][Full Text] [Related]
2. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
Van Roosbroeck K; Calin GA
Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
[TBL] [Abstract][Full Text] [Related]
4. Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
Moussay E; Palissot V; Vallar L; Poirel HA; Wenner T; El Khoury V; Aouali N; Van Moer K; Leners B; Bernardin F; Muller A; Cornillet-Lefebvre P; Delmer A; Duhem C; Ries F; van Dyck E; Berchem G
Mol Cancer; 2010 May; 9():115. PubMed ID: 20487546
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in chronic lymphocytic leukemia (Review).
Zhou XX; Wang X
Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
[TBL] [Abstract][Full Text] [Related]
6. Interaction between miRNAs and signaling cascades of Wnt pathway in chronic lymphocytic leukemia.
Bhattacharya M; Sharma AR; Sharma G; Patra BC; Lee SS; Chakraborty C
J Cell Biochem; 2020 Nov; 121(11):4654-4666. PubMed ID: 32100920
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in chronic lymphocytic leukemia.
Ward BP; Tsongalis GJ; Kaur P
Exp Mol Pathol; 2011 Apr; 90(2):173-8. PubMed ID: 21168405
[TBL] [Abstract][Full Text] [Related]
8. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in Chronic Lymphocytic Leukemia.
Autore F; Ramassone A; Stirparo L; Pagotto S; Fresa A; Innocenti I; Visone R; Laurenti L
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569845
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
11. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
13. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
14. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay.
Doghish AS; Ismail A; Elrebehy MA; Elbadry AMM; Mahmoud HH; Farouk SM; Serea GAA; Elghany RAA; El-Halwany KK; Alsawah AO; Dewidar HI; El-Mahdy HA
Pathol Res Pract; 2022 Sep; 237():154053. PubMed ID: 35926432
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
16. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
[TBL] [Abstract][Full Text] [Related]
17. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
Li PP; Wang X
Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
[TBL] [Abstract][Full Text] [Related]
18. The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia.
Bagheri M; Sarabi PZ; Mondanizadeh M
J Cell Physiol; 2022 Apr; 237(4):2128-2139. PubMed ID: 35315068
[TBL] [Abstract][Full Text] [Related]
19. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]